Answers are grounded in this paper and cite their sources.
Analysis identifies MGMT promoter methylation status in high-grade gliomas using diffusion MRI, suggesting non-invasive diagnostic methods.
Motivation: High-grade gliomas (HGGs) require accurate diagnosis of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation status, which requires invasive biopsies. Therefore, non-invasive diagnostic alternatives are needed. Goal(s): We aimed to assess the feasibility of using time-dependent diffusion MRI to differentiate between methylated and unmethylated MGMT promoters in HGGs. Approach: We used pulsed and oscillating gradient sequences in diffusion MRI to measure microstructural indicators, such as intracellular volume fraction and cellularity, in patients with HGGs. Results: Time-dependent diffusion MRI revealed significant differences between HGGs with methylated vs unmethylated MGMT, providing a highly accurate diagnostic model based on intracellular volume fraction and cellularity. Impact: Our findings may help enabling non-invasive diagnostics for patients with HGGs by providing reliable prognostic tools and may inspire further research into MRI-based techniques for characterizing tumors as well as help guide clinical decision-making for patients unsuitable for biopsy.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: